Escherichia coli Infections Global Clinical Trials Review, H2, 2016

Market: Pharmaceuticals and Healthcare

Global, 61 pages report, published by GlobalData

Keywords : Escherichia coli Infections Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO’s, Terminated, Suspended and Withdrawn trials of Escherichia coli Infections, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.

Report ThumbnailDecember-2016
Escherichia coli Infections Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Escherichia coli Infections Global Clinical Trials Review, H2, 2016" provides an overview of Escherichia coli Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Escherichia coli Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
  • List of Figures
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Escherichia coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Escherichia coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Escherichia coli Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Escherichia coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Escherichia coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
  • Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
  • Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
  • Escherichia coli Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Escherichia coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • GlobalData Methodology 59
  • List of Tables
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Escherichia coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Escherichia coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Escherichia coli Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Escherichia coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Escherichia coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
  • Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
  • Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Escherichia coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
  • Escherichia coli Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Escherichia coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Escherichia coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Escherichia coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Escherichia coli Infections to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Escherichia coli Infections Therapeutics Clinical Trials 26
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29
  • Appendix 58
  • Abbreviations 58
  • Definitions 58
  • Research Methodology 59
  • Secondary Research 59
  • About GlobalData 60
  • Contact Us 60
  • Disclaimer 60
  • Source 61

Please select a license type

Share

Related Products

GlobalDataEscherichia coli Infections Global Clinical Trials Review, H2, 2016Product ThumbnailEscherichia coli Infections Global Clinical Trials Review, H2, 2016, Industry Report available for $2500Product #: 631520
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved